Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy

NCT07357948 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Curie